We are live on ! Find out more
CWG

C WorldWide Group Portfolio holdings

AUM $4.66B
1-Year Est. Return 11.67%
This Fund
S&P 500
This Quarter Est. Return
+8.51%
1 Year Est. Return
+11.67%
3 Year Est. Return
+62.16%
5 Year Est. Return
+69.96%
10 Year Est. Return
+372.2%
AUM
$8.37B
AUM Growth
+$485M
Cap. Flow
-$98.7M
Cap. Flow %
-1.18%
Top 10 Hldgs %
73.28%
Holding
85
New
8
Increased
28
Reduced
16
Closed
4

Top Buys

Rank Stock Value
1
NEE icon
NextEra Energy
NEE
+$302M
2
TSM icon
TSMC
TSM
+$39.3M
3
SCI icon
Service Corp International
SCI
+$37.4M
4
BABA icon
Alibaba
BABA
+$35.1M
5
HDB icon
HDFC Bank
HDB
+$11.9M

Top Sells

Rank Stock Value
1
WFC icon
Wells Fargo
WFC
+$283M
2
XOM icon
ExxonMobil
XOM
+$253M
3
PODD icon
Insulet
PODD
+$6.96M
4
ECL icon
Ecolab
ECL
+$3.34M
5
MRK icon
Merck
MRK
+$3.29M

Sector Composition

Rank Sector Weight
1 Financials 19.86%
2 Consumer Discretionary 17.52%
3 Healthcare 14.25%
4 Consumer Staples 11.24%
5 Technology 8.08%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ISRG icon
26
Intuitive Surgical
ISRG
$127B
$24.8M 0.3%
125,811
– –
DXCM icon
27
DexCom
DXCM
$29.2B
$22.6M 0.27%
412,548
-28,412
-6% -$1.35M
EW icon
28
Edwards Lifesciences
EW
$49.3B
$22.3M 0.27%
287,241
– –
MRK icon
29
Merck
MRK
$326B
$20.6M 0.25%
237,611
-40,062
-14% -$3.29M
HUM icon
30
Humana
HUM
$43.5B
$20.2M 0.24%
55,000
– –
TFX icon
31
Teleflex
TFX
$5.9B
$20M 0.24%
53,000
+8,000
+18% +$2.75M
ILMN icon
32
Illumina
ILMN
$29.2B
$19.2M 0.23%
59,601
– –
ALGN icon
33
Align Technology
ALGN
$12.8B
$19.1M 0.23%
68,428
+10,000
+17% +$2.49M
SRPT icon
34
Sarepta Therapeutics
SRPT
$1.63B
$18.8M 0.22%
145,329
– –
BHVN
35
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
$17M 0.2%
311,751
– –
EXAS
36
DELISTED
Exact Sciences
EXAS
$16.5M 0.2%
178,932
– –
HRTX icon
37
Heron Therapeutics
HRTX
$92.3M
$16.5M 0.2%
702,069
– –
TDOC icon
38
Teladoc Health
TDOC
$1.66B
$16.3M 0.19%
194,834
-40,000
-17% -$3.04M
VRTX icon
39
Vertex Pharmaceuticals
VRTX
$125B
$15M 0.18%
68,557
– –
CHRS icon
40
Coherus Oncology
CHRS
$217M
$14.6M 0.17%
808,464
– –
NVCR icon
41
NovoCure
NVCR
$1.78B
$14.1M 0.17%
166,784
– –
BMRN icon
42
BioMarin Pharmaceuticals
BMRN
$12B
$13.9M 0.17%
163,851
– –
AERI
43
DELISTED
Aerie Pharmaceuticals
AERI
$13.4M 0.16%
556,142
– –
LHCG
44
DELISTED
LHC Group LLC
LHCG
$13.2M 0.16%
95,657
-15,000
-14% -$1.87M
AMRN
45
Amarin Corp
AMRN
$294M
$13.1M 0.16%
30,566
-7,500
-20% -$2.85M
TVRD
46
Tvardi Therapeutics
TVRD
$22.7M
$11.3M 0.14%
19,541
– –
STML
47
DELISTED
Stemline Therapeutics, Inc.
STML
$10.6M 0.13%
998,677
– –
INSM icon
48
Insmed
INSM
$22.5B
$10.6M 0.13%
443,110
– –
PODD icon
49
Insulet
PODD
$11.8B
$9.91M 0.12%
57,908
-41,764
-42% -$6.96M
GWPH
50
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
$9.77M 0.12%
93,473
+70,000
+298% +$7.85M
1
2
3 4

Similar funds

ASC
Atalanta Sosnoff Capital New York $4.66B AUM 41.34% 1-Year Est. Return
MA
Mutual Advisors Omaha, Nebraska $4.67B AUM 17.48% 1-Year Est. Return
KCM
Kornitzer Capital Management Shawnee Mission, Kansas $4.65B AUM 23.83% 1-Year Est. Return
EI
EFG International Zurich $4.67B AUM
ACM
Abrams Capital Management Boston, Massachusetts $4.64B AUM 1.52% 1-Year Est. Return
VCM
Voleon Capital Management Berkeley, California $4.64B AUM 38.78% 1-Year Est. Return
LPPI
Local Pensions Partnership Investment London, United Kingdom $4.63B AUM 13.51% 1-Year Est. Return
CCWM
Cassaday & Co Wealth Management Mclean, Virginia $4.69B AUM 20.56% 1-Year Est. Return

C WorldWide Group's Q4 2019 Portfolio in Review

As of Q4 2019, C WorldWide Group held 85 positions worth $8.37B, up 6.1% from $7.89B the previous quarter. Its ten largest holdings account for 73% of the portfolio.

C WorldWide Group's Q4 2019 filing shows 8 new, 28 increased, 16 reduced and 4 closed positions. Its largest new stake was NextEra Energy: 5,165,968 shares worth $313M. The largest sale was Wells Fargo, an estimated $283M.

By sector, the portfolio is most concentrated in Financials at 20% of assets, down from 22% a quarter earlier, followed by Consumer Discretionary and Healthcare.

  • C WorldWide Group's largest Q4 2019 buy was NextEra Energy: 5,165,968 shares worth $313M.
  • C WorldWide Group added most to TSMC in Q4 2019, an estimated $39.3M increase.
  • C WorldWide Group's biggest Q4 2019 reduction was Insulet, cutting an estimated $6.96M.
  • C WorldWide Group fully exited Wells Fargo in Q4 2019, selling an estimated $283M.
  • C WorldWide Group's ten largest holdings make up 73% of its $8.37B portfolio in Q4 2019.
  • C WorldWide Group opened 8 new positions and closed 4 in Q4 2019.
  • C WorldWide Group's portfolio value rose 6.1% quarter-over-quarter to $8.37B.

Based on C WorldWide Group's 13F filing for Q4 2019, filed 5 Feb 2020.